Johnson Chemical Pharmaceutical Works Statistics

Total Valuation

Johnson Chemical Pharmaceutical Works has a market cap or net worth of TWD 3.22 billion. The enterprise value is 2.31 billion.

Market Cap	3.22B
Enterprise Value	2.31B

Important Dates

The next estimated earnings date is Friday, March 28, 2025.

Earnings Date	Mar 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Johnson Chemical Pharmaceutical Works has 44.93 million shares outstanding. The number of shares has increased by 37.71% in one year.

Current Share Class	n/a
Shares Outstanding	44.93M
Shares Change (YoY)	+37.71%
Shares Change (QoQ)	+0.13%
Owned by Insiders (%)	19.96%
Owned by Institutions (%)	n/a
Float	35.96M

Valuation Ratios

The trailing PE ratio is 39.19.

PE Ratio	39.19
Forward PE	n/a
PS Ratio	5.19
PB Ratio	1.91
P/TBV Ratio	1.91
P/FCF Ratio	55.41
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.59, with an EV/FCF ratio of 39.84.

EV / Earnings	28.27
EV / Sales	3.74
EV / EBITDA	19.59
EV / EBIT	23.92
EV / FCF	39.84

Financial Position

The company has a current ratio of 7.65, with a Debt / Equity ratio of 0.09.

Current Ratio	7.65
Quick Ratio	6.82
Debt / Equity	0.09
Debt / EBITDA	1.27
Debt / FCF	2.58
Interest Coverage	25.90

Financial Efficiency

Return on equity (ROE) is 4.99% and return on invested capital (ROIC) is 3.31%.

Return on Equity (ROE)	4.99%
Return on Assets (ROA)	3.10%
Return on Capital (ROIC)	3.31%
Revenue Per Employee	3.64M
Profits Per Employee	481,347
Employee Count	167
Asset Turnover	0.32
Inventory Turnover	2.73

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -15.67% in the last 52 weeks. The beta is -0.37, so Johnson Chemical Pharmaceutical Works's price volatility has been lower than the market average.

Beta (5Y)	-0.37
52-Week Price Change	-15.67%
50-Day Moving Average	71.46
200-Day Moving Average	71.15
Relative Strength Index (RSI)	52.85
Average Volume (20 Days)	70,665

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Johnson Chemical Pharmaceutical Works had revenue of TWD 618.33 million and earned 81.83 million in profits. Earnings per share was 1.83.

Revenue	618.33M
Gross Profit	246.95M
Operating Income	96.69M
Pretax Income	105.97M
Net Income	81.83M
EBITDA	118.08M
EBIT	96.69M
Earnings Per Share (EPS)	1.83

Full Income Statement

Balance Sheet

The company has 1.05 billion in cash and 149.73 million in debt, giving a net cash position of 903.91 million or 20.12 per share.

Cash & Cash Equivalents	1.05B
Total Debt	149.73M
Net Cash	903.91M
Net Cash Per Share	20.12
Equity (Book Value)	1.68B
Book Value Per Share	37.47
Working Capital	1.14B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 83.32 million and capital expenditures -25.26 million, giving a free cash flow of 58.06 million.

Operating Cash Flow	83.32M
Capital Expenditures	-25.26M
Free Cash Flow	58.06M
FCF Per Share	1.29

Full Cash Flow Statement

Margins

Gross margin is 39.94%, with operating and profit margins of 15.64% and 13.23%.

Gross Margin	39.94%
Operating Margin	15.64%
Pretax Margin	17.14%
Profit Margin	13.23%
EBITDA Margin	19.10%
EBIT Margin	15.64%
FCF Margin	9.39%

Dividends & Yields

This stock pays an annual dividend of 1.50, which amounts to a dividend yield of 2.09%.

Dividend Per Share	1.50
Dividend Yield	2.09%
Dividend Growth (YoY)	-25.08%
Years of Dividend Growth	1
Payout Ratio	82.27%
Buyback Yield	-37.71%
Shareholder Yield	-35.62%
Earnings Yield	2.55%
FCF Yield	1.80%

Dividend Details

Stock Splits

The last stock split was on July 30, 2014. It was a forward split with a ratio of 1.125.

Last Split Date	Jul 30, 2014
Split Type	Forward
Split Ratio	1.125

Scores

Johnson Chemical Pharmaceutical Works has an Altman Z-Score of 9.11.

Altman Z-Score	9.11
Piotroski F-Score	n/a